Skip to main content

Table 1 Clinical characteristics of all patients in this study (n = 138)

From: IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis

Clinicopathologic parameters

PTC

PTC + HT

p-value

N

N

Gender

  

0.000***

 Male

26

2

 

 Female

63

47

 

Age (years)

 Mean

42.3 ± 12.3

39.9 ± 12.5

0.272

 < 55

73

43

0.379

 ≥ 55

16

6

 

Tumor size (cm)

 Mean

1.2 ± 0.7

1.3 ± 0.9

0.330

 ≤ 1

52

22

0.127

 > 1

37

27

 

Multifocal lesions

  

0.040*

 Positive

23

21

 

 Negative

66

28

 

Extrathyroidal invasion

  

0.339

 Positive

8

7

 

 Negative

81

42

 

Lymph node metastasis

  

0.625

 Positive

47

28

 

 Negative

42

21

 

TNM stage 8th

  

0.254

 I, II

88

47

 

 III, IV

1

2

 
  1. *p < 0.05; ***p < 0.001
  2. PTC papillary thyroid cancer, HT Hashimoto’s thyroiditis